EpimAb_LogoPlanegg/Martinsried and Shanghai, February 27, 2025. Medigene AG (Medigene, FSE: MDG1, Prime Standard) and EpimAb Biotherapeutics, Inc. (EpimAb), announced that the companies have entered ...

Meg O'Neill speaks to Livewire on Woodside's 2024 results and the major projects it has coming online to deliver value ...

As part of its End-To-End Platform, Medigene discovers natural TCR sequences with high specificity, sensitivity and safety (3S). These optimal 3S TCRs can subsequently be merged with a Cluster of ...

Q4 2024 Earnings Conference Call February 26, 2025 8:30 AM ETCompany ParticipantsMarcus Lemonis – Chairman and ...